Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 74

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 74
---
 to publicly reaffirm the Board Recommendation within five (5) Business Days after having been requested in writing by the Purchaser to do so (or in the event that the Meeting is scheduled to occur        
 within such five Business Day period, prior to the third Business Day prior to the date of the Meeting), or (II) withholds or withdraws (or amends, modifies or qualifies in a manner adverse to Parent or the Purchaser) or proposes publicly to        
 withhold or withdraw (or amend, modify or qualify in a manner adverse to Parent or the                                                                                                                                                                   |

- 42 -

| Purchaser) any of the recommendations of the Transaction Committee referred to in Paragraph 43(a) of Schedule E to this Agreement, respectively, (2) accepts, approves, endorses or                                                             
 recommends, or publicly proposes to accept, approve, endorse or recommend an Acquisition Proposal, or (3) takes no position or a neutral position with respect to an Acquisition Proposal for more than five (5) Business Days after the public 
 announcement of such Acquisition Proposal (or beyond the third Business Day prior to the date of the Meeting, if sooner) (in each of the cases set forth in Clause (1), (2) or (3), “Change of Recommendation”); or (4) the Board               
 or any committee of the Board accepts, approves, endorses, recommends or authorizes the Company to enter into a written agreement concerning a Superior Proposal;                                                                               |

| (C) | Material Adverse Change. There has occurred a Material Adverse Change after the date of this 
 Agreement; or                                                                                |

| (D) | Breach of Non-Solicit. The Company breaches any covenant or obligation in Section 6.1 or 
 Section 6.2 in any material respect.                                                     |

| (iv) | by either the Company or the Purchaser |

| (A) | No Required Approval by Shareholders. The Arrangement Resolution is not approved by the Shareholders at                                                                                                                                     
 the Meeting in accordance with the Interim Order provided that a Party may not terminate this Agreement pursuant to this 8.2(a)(iv)(A) [No Required Approval by Shareholders] if the failure to obtain the approval of the Shareholders has 
 been caused by, or is a result of, a breach by such Party of any of its representations or warranties or the failure of such Party to perform any of its covenants or agreements under this Agreement;                                      |

| (B) | Illegality. After the date of